Sort   by:  
 Page size 
UnknownPhase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.
Not available
S-EPMC3675699 | biostudies-literature
UnknownRandomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes.
Not available
S-EPMC4878053 | biostudies-literature
UnknownClearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6008108 | biostudies-literature
UnknownEffect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.
Not available
S-EPMC10734790 | biostudies-literature
UnknownCombination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
Not available
S-EPMC11149044 | biostudies-literature
UnknownClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Not available
S-EPMC7255743 | biostudies-literature
UnknownAssociation of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Not available
S-EPMC8377563 | biostudies-literature
UnknownImpact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Not available
S-EPMC10033295 | biostudies-literature
UnknownRacial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
Not available
S-EPMC8961318 | biostudies-literature
UnknownA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
Not available
S-EPMC7598547 | biostudies-literature
Sort   by:  
 Page size